43. The representative of India said that his views were adequately reflected in document JOB(02)/102. He said that he would prefer a broad interpretation of product coverage that would help countries that had insufficient or no manufacturing capacity to develop indigenous production capabilities. To this end, it was necessary for importing countries to have access to the active ingredient at least in the preliminary stages of development of their own industries. He supported the statements of Brazil and of the European Communities and said that "constructive ambiguity" in the definition of product coverage would help Member countries to deal with public health problems in a comprehensive manner.
